miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
16966691 Pancreatic cancer - 260350 (Pancreatic endocrine tumors - 0) Cancer pancreas miRNA overexpression - 5.91 - Patient study phenotype-control miRNA microarray
18459106 Prostate cancer - 176807 Cancer adenocarcinoma cell miRNA overexpression - 2.03 - Patient study phenotype-phenotype miRNA microarray
18230780 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.1 - Patient study phenotype-control quantitative PCR
16461460 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - - - Patient study phenotype-control miRNA microarray
16461460 Lung cancer - 211980 Cancer lung miRNA overexpression - - - Patient study phenotype-control miRNA microarray
16461460 Gastric cancer - 137215 Cancer stomach miRNA overexpression - - - Patient study phenotype-control miRNA microarray
16461460 Pancreatic cancer - 260350 Cancer pancreas miRNA overexpression - - - Patient study phenotype-control miRNA microarray
17363563 Leukemia, acute myeloid - 601626 Cancer HL-60 cell miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Leukemia, chronic myeloid - 608232 Cancer K-562 cell miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Multiple myeloma - 254500 Cancer RPMI-8226 cell miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Leukemia/lymphoma, chronic B-cell - 151400 Cancer lymphoma cell line miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Glioblastoma multiforme, somatic - 137800 Cancer U-251 cell miRNA downregulation - 3.2 - Cell culture study quantitative PCR
16549775 Leukemia, acute myelogenous - 601626 Cancer leukemia cell miRNA overexpression 7.59 4.19 - Cell culture study miRNA microarray
17712037 Cardiomyopathy, dilated - 115200 Cardiovascular myocardium miRNA overexpression - 1.39 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) Muscular muscle miRNA overexpression - 1.88 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2A - 253600 Muscular muscle miRNA overexpression - 2.0 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2B - 253601 Muscular muscle miRNA overexpression - 1.75 - Patient study phenotype-control miRNA microarray
17942673 Miyoshi myopathy - 254130 Muscular muscle miRNA overexpression - 1.89 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 2.85 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Dermatomyositis - 0) Muscular muscle miRNA overexpression - 1.64 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Polymyositis - 0) Muscular muscle miRNA overexpression - 2.14 - Patient study phenotype-control miRNA microarray
17712037 Supravalvar aortic stenosis - 185500 Cardiovascular myocardium miRNA overexpression - 1.5 - Patient study phenotype-control miRNA microarray
17622355 Psoriasis, susceptibility to - 177900 Dermatological skin miRNA downregulation - 1.72414 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA overexpression - 1.6 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA overexpression - 3.06 - Cell culture study quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 2.0 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 3.22581 - Patient study phenotype-phenotype quantitative PCR
18182067 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA downregulation - 1.42857 - Patient study phenotype-control miRNA microarray
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA overexpression - 2.93 - Cell culture study quantitative PCR
17922033 Cancer - 0 (Leiomyosarcoma - 0) Cancer muscle miRNA downregulation - 4.16667 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA overexpression - 1.89 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA overexpression - 3.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA overexpression - 2.46 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 2.08333 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA downregulation - 1.0989 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 1.42857 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA overexpression - 1.07 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 2.96 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 5.1 - Cell culture study quantitative PCR
18766170 Lung cancer - 211980 Cancer serum miRNA overexpression - - - Patient study phenotype-control deep sequencing
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 1.6 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA overexpression - 9.27 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 2.07 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA overexpression - 7.98 - Cell culture study quantitative PCR
15504739 - - adipocyte miRNA overexpression - 1.45 - Bioprocess study miRNA microarray